ERYTECH to Participate in Fireside Chat at Jefferies Virtual Healthcare Conference

ERYTECH Pharma announced that its CEO, Gil Beyen, will be participating in a fireside chat at the Jefferies Virtual Healthcare Conference at 12:00pm EST / 05:00pm GMT / 6:00pm CET on November 18, 2020

The webcast can be followed via the link (this link will be available for 90 days): https://wsw.com/webcast/jeff141/eryp/1869600

ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host a Third Quarter 2020 conference call and webcast on Friday, November 6, 2020, at 2:30 PM CET/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 2943988#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/cm8pkxrh

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 2943988#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at investors.erytech.com

>> Link to slideshow

ERYTECH to host a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announces the hosting of a Key Opinion Leader (KOL) Event to discuss the medical need in pancreatic cancer and the potential role of eryaspase in this setting.

On September 29, 2020 at 10:00 am ET, ERYTECH will host a call that will include a presentation by KOL Dr. Manuel Hidalgo, MD, Ph.D. (Weill Cornell Medicine/New York Presbyterian Hospital), who will discuss the current treatment landscape and unmet medical need in treating patients with pancreatic cancer, and an update by Erytech’s management on eryaspase and the TRYbeCA-1 trial. Dr. Hidalgo and management will be available to answer questions at the conclusion of the call.

Registration for the event is available at the following link: https://lifescipartners.zoom.us/webinar/register/2815964896473/WN_9NL0s4RxTBavKypVlPRZ-A

An archive of the webcast can viewed via the following link : https://lifescipartners.zoom.us/rec/play/c9w-ng4P4zjwGXzvoy5ZcProcejxaYKd2pCobz1yA600NlaDUcOwDvkF2OqF21DOOQfRiYnUcbJXEEn8.jA0N2S95gL-AQpzH?autoplay=true&startTime=1601388021000

ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its second quarter 2020 conference call and webcast on Tuesday, September 22, 2020, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 8585556#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/ypvwj59i

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 8585556#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com

>> Link to slideshow

ERYTECH to Host on May 7, 2020 First Quarter Conference Call and Business Update

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its 2020 first quarter conference call and webcast on Wednesday, May 7, 2020, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 9688486#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/ub95wf2d

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 9688486#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com

>> Link to slideshow

ERYTECH to Host Fourth Quarter and Full Year 2019 Conference Call and Business Update

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its fourth quarter and full year 2019 conference call and webcast on Tuesday, March 17, 2020, at 1:30 PM CET/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 1671839#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/h2zjygca

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 1671839#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

>> Link to slideshow

Menu